当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Krick Wilson
Rift Valley Fever (RVF) is a viral zoonosis spread by mosquitoes. It was first discovered in Kenya in 1930, and since then, it has spread to many African nations and the Arabian Peninsula. Human infection can result in a wide range of clinical outcomes, from self limiting febrile illness to life threatening hemorrhagic diatheses and miscarriage in pregnant women. The RVF virus primarily infects domestic livestock (sheep, goats, cattle) resulting in high rates of neonatal mortality and abortion. RVF has been responsible for numerous outbreaks in Africa and the Arabian Peninsula since its discovery, with significant effects on human and animal health. However, the lack of licensed human vaccines or therapeutics limits options for controlling RVF outbreaks. The World Health Organization places RVF at the top of its priority list for urgent research and development of measures to prevent and control future outbreaks. The current understanding of RVF, including its epidemiology, pathogenesis, clinical manifestations, and vaccine development status, are highlighted in this review.